All posts by Cooley

2021 Update: 10 Key Considerations for Going Public with a SPAC

It is a reasonable extrapolation – and we are nothing at Cooley if not wildly reasonable – that, since the beginning of time, more operating companies are considering going public through a merger with a SPAC (Special Purpose Acquisition Company). While the number of SPAC IPOs may have peaked in […]

Past Event: SPACs – The Next Generation of IPOs or Just a Fad?

Driven by ongoing market pressures brought on by the COVID-19 pandemic, we have seen a surge of interest in special purpose acquisition (SPAC) transactions from companies across sectors. During this session, we heard from industry lawyers, exchange executives, and investment bankers on key considerations for navigating a SPAC merger, as […]

Past Event: Pacific Southwest Region SPAC / IPO Roundtable

Cooley partners Dave Peinsipp and Sean Clayton, Deloitte, Nasdaq and an investment banker well-versed in the IPO and SPAC processes to share insights on the next normal.

Past Event: Deloitte IPO Bootcamp 2020

Should you IPO? Timing the market can be difficult so it’s important to prepare your company well in advance of your targeted offering date. This exclusive workshop designed for C-suite executives, accounting and finance leaders of pre-IPO companies will offer actionable insights and best practices for a successful IPO. This […]

SPAC Transactions – Considerations for Target-Company CFOs

Although special-purpose acquisition companies (SPACs) have been used for decades as alternative investment vehicles, they have recently come into vogue as seasoned investors and management teams have turned to SPACs to mitigate the increased market volatility risk of traditional initial public offerings (IPOs). In fact, 2020 has been a record-breaking […]

A Couple of Quick Items Regarding IPO Alternatives

Here are two quick items regarding popular IPO alternatives, SPACs (special purpose acquisition corporations) and primary direct listings: SPACs.  In an interview on CNBC with Andrew Ross Sorkin on Thursday, SEC Chair Jay Clayton addressed the recent SPAC frenzy. (Very loosely, SPACs are companies with no real operations formed to […]

Past Event: Dealmakers Roundtable: SPACs!

On September 24th, 2020, Cooley partners Garth Osterman, Rama Padmanabhan, and Dave Peinsipp led a panel discussing the topics listed below. Topics include The recent acceleration of SPAC M&A activity Key timing considerations for a SPAC business combination The ways in which PIPEs and debt securities come into play Changing […]

Past Event: Cell & Gene Meeting on The Mesa

The Cell & Gene Meeting on the Mesa is the sector’s foremost annual conference bringing together senior executives and top decision-makers in the industry to advance cutting-edge research into cures. This conference covers commercialization hurdles facing the cell and gene therapy sector as well as a wide range of topics […]

Past Event: Bay Area IPO Readiness Workshop

Cooley partner Dave Peinsipp, Deloitte and leaders from other organizations well-versed in the IPO, direct listing and SPAC processes shared their insights on the next normal. Topics include Current market conditions Regulatory considerations How to prepare for the IPO process Life as a public company Actionable insights from a CFO/controller […]

Past Event: The 2020 IPO Comeback Series

After IPO issuances came to a near-halt in late Q1 and early Q2 2020, the window reopened wide this summer when much-needed liquidity infused the markets and led to one of the strongest months for IPOs in 13 years. This two-part executive webinar series was on the novel challenges of […]